Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Zorguitgaven kanker stijgen vooral door nieuwe behandelingen
mrt 2025 | Dermato-oncologie, Leukemie, Longoncologie, MM